Integral Diagnostics | IDX - Des Atouts

Prix De L'Action
2.27
Variation Quotidienne
-0.03 -1.30%
Mensuellement
-4.22%
Annuel
0%
Q2 Prévisions
2.20




Des Atouts Changement Date
Alcidion AUD 118.08M 2.46M 2025-12
Ansell USD 3.33B 3.2M 2025-12
Cochlear AUD 2.79B 31.3M 2025-12
CSL USD 37.9B 1.5B 2025-12
Healius AUD 3.07B 84.2M 2024-12
Mayne Pharma AUD 1.14B 9.47M 2024-06
Monash IVF AUD 510.21M 17.6M 2025-12
Nanosonics AUD 279.25M 6.77M 2025-12
Polynovo AUD 123.37M 4.04M 2025-12
Ramsay Health Care AUD 21.7B 777.8M 2025-12
ResMed USD 8.5B 195.02M 2025-12
Sigma Healthcare AUD 8.29B 6.91B 2025-12
Sonic Healthcare AUD 15.38B 550.57M 2024-12
Telix Pharmaceuticals AUD 1.16B 25.97M 2025-12